Estados financieros detallados de Larimar Therapeutics, Inc. (LRMR): cuenta de resultados, balance general y flujo de caja. Sigue la evolución de márgenes, deuda, liquidez y rentabilidad año a año con hasta 20 años de histórico.
Resumen del Análisis
Márgenes de los últimos 12 meses: margen bruto 0.0%, margen operativo 0.0%, margen neto 0.0%.
Al precio actual de $3.93, LRMR presenta beneficios negativos (P/E no significativo) y un ROE del -137.39%. La capitalización bursátil es de $408M.
Cuenta de Resultados (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Ingresos | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Coste de Ventas | $212000 | $188000 | $261000 | $78000 | $155000 | 0 | 0 | 0 | 0 | 0 |
| Beneficio Bruto | -$212000 | -$188000 | -$261000 | -$78000 | -$155000 | 0 | 0 | 0 | 0 | 0 |
| I+D | $39.8M | $41.7M | $49.5M | $20.8M | $31.3M | $38.4M | $24.2M | $27.7M | $73.3M | $154.2M |
| Generales y Administrativos | $17.1M | $11.9M | $12.9M | $2.4M | $11.4M | $12.1M | $12.3M | $14.1M | $17.6M | $18.3M |
| Gastos Operativos | $56.9M | $53.7M | $62.5M | $23.2M | $42.6M | $50.5M | $36.5M | $41.8M | $90.9M | $172.5M |
| Beneficio Operativo | -$57.1M | -$53.9M | -$62.7M | -$23.2M | -$42.8M | -$50.5M | -$36.5M | -$41.8M | -$90.9M | -$172.5M |
| EBITDA | -$57.4M | -$52.6M | -$60.8M | -$23.1M | -$42.6M | -$50.3M | -$35.0M | -$36.6M | -$80.3M | -$165.3M |
| Gastos por Intereses | $347000 | $971000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Beneficio Antes de Impuestos | -$58.2M | -$52.9M | -$63.0M | -$23.1M | -$42.5M | -$50.6M | -$35.4M | -$36.9M | -$80.6M | -$165.7M |
| Impuestos | -$300000 | -$900000 | -$1.6M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Beneficio Neto | -$57.9M | -$52.0M | -$61.4M | -$23.1M | -$42.3M | -$50.6M | -$35.4M | -$36.9M | -$80.6M | -$165.7M |
| BPA | $-25.44 | $-22.76 | $-22.85 | $-2.51 | $-3.56 | $-2.93 | $-1.33 | $-0.84 | $-1.32 | $-2.27 |
| BPA Diluido | $-25.44 | $-22.76 | $-22.85 | $-2.51 | $-3.56 | $-2.93 | $-1.33 | $-0.84 | $-1.32 | $-2.27 |
| Acciones en Circulación (Diluidas) | $2.3M | $2.3M | $2.7M | $9.2M | $11.9M | $17.2M | $25.8M | $43.9M | $61.3M | $72.9M |
Balance (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Caja y Equivalentes | $32.4M | $40.8M | $49.3M | $1.0M | $68.1M | $70.1M | $26.8M | $26.7M | $33.2M | $85.4M |
| Inversiones a Corto | $96.8M | $61.3M | $68.7M | 0 | $24.5M | 0 | $91.6M | $60.0M | $150.2M | $51.4M |
| Cuentas por Cobrar | $347000 | $946000 | $1.5M | $158000 | $32000 | $208000 | 0 | $332000 | $1.1M | $747000 |
| Inventario | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Corrientes | $130.9M | $104.9M | $121.3M | $4.8M | $98.0M | $72.2M | $120.7M | $90.2M | $195.3M | $142.0M |
| Inmovilizado Material | $661000 | $528000 | $375000 | $361000 | $5.0M | $4.5M | $3.7M | $3.8M | $3.7M | $2.7M |
| Fondo de Comercio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Intangibles | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Totales | $131.6M | $105.5M | $121.8M | $5.2M | $104.7M | $78.7M | $126.4M | $95.9M | $200.2M | $145.8M |
| Cuentas por Pagar | 0 | 0 | $909000 | $3.5M | $2.6M | $1.7M | $1.7M | $1.3M | $2.4M | $5.2M |
| Deuda a Corto | $3.6M | 0 | $5.5M | 0 | 0 | 0 | 0 | 0 | 0 | $1.1M |
| Pasivos Corrientes | $9.9M | $7.3M | $13.3M | $5.9M | $9.0M | $8.8M | $10.7M | $9.5M | $24.4M | $64.8M |
| Deuda a Largo | 0 | $20.0M | $15.2M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Pasivos Totales | $9.9M | $27.3M | $28.5M | $5.9M | $15.0M | $14.3M | $15.5M | $14.2M | $28.4M | $67.8M |
| Reservas | -$237.5M | -$289.6M | -$350.9M | -$23.1M | -$65.6M | -$116.2M | -$151.6M | -$188.6M | -$269.2M | -$434.8M |
| Patrimonio Neto | $121.7M | $78.2M | $93.3M | -$694000 | $89.7M | $64.4M | $110.9M | $81.7M | $171.8M | $78.1M |
| Deuda Total | $3.6M | $20.0M | $20.6M | $97000 | $6.5M | $6.0M | $5.4M | $5.5M | $5.1M | $4.1M |
| Deuda Neta | -$125.6M | -$82.1M | -$97.4M | -$912000 | -$86.1M | -$64.1M | -$113.0M | -$81.2M | -$178.3M | -$132.8M |
| Capital Circulante | $121.0M | $97.6M | $108.0M | -$1.1M | $89.0M | $63.4M | $110.0M | $80.7M | $170.9M | $77.2M |
Flujo de Caja (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Beneficio Neto | -$57.9M | -$52.0M | -$61.4M | -$23.1M | -$42.5M | -$50.6M | -$35.4M | -$36.9M | -$80.6M | -$165.7M |
| Amortizaciones | $212000 | $188000 | $261000 | $78000 | $155000 | $326000 | $318000 | $311000 | $318000 | $350000 |
| Compensación en Acciones | 0 | 0 | $173000 | $129000 | $2.2M | $5.5M | $6.6M | $7.6M | $8.8M | $7.0M |
| Cambio en Capital Circulante | -$5.5M | -$99000 | $593000 | $226000 | -$2.0M | $2.7M | $1.7M | -$2.5M | $6.2M | $47.1M |
| Flujo de Caja Operativo | -$52.0M | -$43.8M | -$51.5M | -$22.7M | -$42.2M | -$42.1M | -$27.6M | -$33.5M | -$70.8M | -$113.2M |
| Inversiones (CapEx) | -$660000 | -$55000 | -$108000 | -$83000 | -$62000 | -$333000 | -$100000 | -$163999 | -$515000 | -$91000 |
| Adquisiciones | 0 | 0 | $6.8M | 0 | -$1.3M | -$24502 | $90860 | 0 | 0 | 0 |
| Recompra de Acciones | $220000 | $195000 | $67.2M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividendos Pagados | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Flujo de Caja Libre | -$52.6M | -$43.8M | -$51.6M | -$22.8M | -$42.3M | -$42.4M | -$27.7M | -$33.6M | -$71.3M | -$113.3M |
Crecimiento y Márgenes (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Crecimiento Beneficio Neto (anual) | +10.1% | -18.0% | +62.3% | -83.0% | -19.6% | +30.2% | -4.5% | -118.1% | -105.5% | |
| Crecimiento BPA (anual) | +10.5% | -0.4% | +89.0% | -41.8% | +17.7% | +54.6% | +36.8% | -57.1% | -72.0% | |
| Cambio en Acciones (anual) | +0.5% | +17.5% | +243.1% | +29.0% | +44.4% | +50.1% | +70.4% | +39.5% | +19.1% | |
| Crecimiento FCF (anual) | +16.7% | -17.7% | +55.8% | -85.5% | -0.4% | +34.8% | -21.5% | -112.0% | -59.0% | |
| Tasa Impositiva Efectiva | 0.5% | 1.7% | 2.5% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% |
Datos por Acción (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| FCF por Acción | $-23.14 | $-19.18 | $-19.21 | $-2.47 | $-3.56 | $-2.47 | $-1.07 | $-0.77 | $-1.16 | $-1.55 |
| Dividendo por Acción | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Acciones en Circulación (Básicas) | $2.3M | $2.3M | $2.7M | $9.2M | $11.9M | $17.2M | $25.8M | $43.9M | $61.3M | $72.9M |
Qué mirar en Biotech
La mayoría de biotechs pequeñas pierden dinero. Analizarlas con P/E no tiene sentido — mira caja y pipeline.
- Cash Runway — Meses de caja al ritmo de gasto actual. <18 meses = riesgo de dilución urgente
- Cash burn anual — Ritmo al que queman caja operativa. Comparar con posición de caja para proyectar runway
- Total Debt — Biotech sin ingresos + deuda = receta para bancarrota
- I+D / Capitalización — Cuánto invierten en pipeline vs lo que vale la empresa — indicador de intensidad investigadora
- Market cap / Cash — Si cotiza cerca de su caja, el mercado le da ~0 valor al pipeline — puede ser oportunidad o trampa
Rentabilidad
| Rentabilidad sobre capital | -137.39% |
| Rentabilidad sobre capital invertido | -135.25% |
| Rentabilidad sobre activos | -104.42% |
| Margen bruto | 0.00% |
| Margen operativo | 0.00% |
| Margen neto | 0.00% |
Salud financiera
| Deuda / Patrimonio | 0.04 |
| Ratio corriente | 4.70 |
| Piotroski F-Score | 1 |
| Altman Z-Score | -4.98 |
Ratios Clave (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| P/E | -1.50 | -2.44 | -2.60 | -5.31 | -6.01 | -3.68 | -3.11 | -5.42 | -2.93 | -1.68 |
| P/VC | 0.71 | 1.62 | 1.71 | -176.84 | 2.84 | 2.88 | 0.96 | 2.44 | 1.38 | 3.56 |
| P/V | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Margen Bruto | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Margen Operativo | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Margen Neto | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Empresas relacionadas: ACIU · ALT · AMRN · ANNX · ANRO · DBVT · ENGN
Explorar sector: Healthcare · Biotechnology
Más secciones de LRMR: Resumen · Valoración · Estadísticas · Estimaciones · Técnico · Propiedad · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones